Ako Capital Llp

Institutional investor · Portfolio as of Q3 2019

Top Holdings21 positions

Checking export access…
Activity:
2.7M$517.2M12.6%———
—
RACE

Ferrari N.V.

2.6M$394.8M9.6%$146.250.00%
1 qtr
First report
0
GRFS
GRFS
ADR

Grifols, S.A.

12.2M$243.7M5.9%$18.540.00%
1 qtr
First report
0
NKE

Nike, Inc.

2.4M$228.8M5.6%$84.190.00%
1 qtr
First report
0
V

Visa Inc.

1.2M$211.4M5.1%$163.310.00%
1 qtr
First report
0
1.5M$210.1M5.1%——
1 qtr
First report
0
ALLE

Allegion plc

1.9M$194.8M4.7%$94.640.00%
1 qtr
First report
0
EL

The Estee Lauder Companies, Inc.

976,085$194.2M4.7%$181.550.00%
1 qtr
First report
0
PG

The Procter & Gamble Company

1.5M$191.7M4.7%$103.430.00%
1 qtr
First report
0
GOOG

Alphabet Inc.

147,982$180.4M4.4%$60.380.00%
1 qtr
First report
0
AXP

American Express Company

1.5M$172.7M4.2%$107.620.00%
1 qtr
First report
0
ANSS
ANSSAcquired

ANSYS INC

777,293$172.1M4.2%——
1 qtr
First report
0
ABEV
ABEV
ADR

Ambev S.A.

34.7M$160.4M3.9%$3.480.00%
1 qtr
First report
0
MAR

Marriott International

1.3M$155.9M3.8%$118.340.00%
1 qtr
First report
0
CME

CME Group Inc.

707,185$149.5M3.6%$161.140.00%
1 qtr
First report
0
VRSK

Verisk Analytics, Inc.

932,967$147.5M3.6%$150.740.00%
1 qtr
First report
0
EW

Edwards Lifesciences Corporation

643,499$141.5M3.4%$73.300.00%
1 qtr
First report
0
FICO

Fair Isaac Corporation

423,492$128.5M3.1%$303.520.00%
1 qtr
First report
0
ALC

Alcon Inc.

2.1M$123.1M3.0%$57.180.00%
1 qtr
First report
0
ZTS

Zoetis Inc.

762,943$95.1M2.3%$115.680.00%
1 qtr
First report
0
$4.1B
AUM
21
Positions
Q3 2019
Filing
HI rating · 5.0/5
Quarterly 13F Value Change
Not enough history yet
Activity profile
Q3'19

First report: nothing earlier to compare

Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
<1Q100%1-4Q0%1-2Y0%2Y+0%

Ako Capital Llp manages $4.1B across 21 positions as of Q3 2019. Top holdings: LIN (12.6%), RACE (9.6%), GRFS (5.9%). Fund DNA: Concentrated Value. HoldingsIntel Score: 5/5.0.

Q3 2019 Summary

First quarter we have for this fund: 21 positions, nothing earlier to compare. No standout high-conviction moves this quarter. Portfolio: $4.1B across 21 positions.

Top holdings by portfolio weight

Total AUM$4B
LIN12.59%
RACE9.61%
GRFS5.93%
NKE5.57%
V5.15%
UTX5.12%
ALLE4.74%
EL4.73%
PG4.67%
GOOG4.39%
Other4.20%

Portfolio allocation by GICS sector

Sectors9
Consumer Cyclical18.98%
Financial Services15.27%
Healthcare14.69%
Consumer Defensive13.30%
Basic Materials12.59%
Unknown9.31%
Industrials8.33%
Communication Services4.39%
Technology3.13%

Behavioral investing profile

Checking access…
Concentrated Value- primarily Consumer Cyclical, Financial Services, Healthcare
Compare DNA across all funds
7-dimension, SEC 13F-derived research score
Elite(5.0 / 5.0)
Holdings P&L78
Conviction67
Concentration100
Checking access…

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
2Q
MAMAMastercard Incorporated
Q1 2026 → Q2 2026+89,832 shares+$40,404
2Q
ALCALCAlcon Inc.
Q1 2026 → Q2 2026+2M shares+$42,590
Checking access…

Famous Investors' Portfolios

What the most-followed managers hold, and what they bought and sold each quarter.

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Optional analytics helps us improve. How it’s used